{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:00:18Z","timestamp":1780322418776,"version":"3.54.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019345","name":"King Salman Center for Disability Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The glutamate-gated ion channels known as N-methyl-d-aspartate receptors (NMDARs) are important for both normal and pathological brain function. Subunit-selective antagonists have high therapeutic promise since many pathological conditions involve NMDAR over activation, although few clinical successes have been reported. Allosteric inhibitors of GluN2B-containing receptors are among the most potential NMDAR targeting drugs. Since the discovery of ifenprodil, a variety of GluN2B-selective compounds have been discovered, each with remarkably unique structural motifs. These results expand the allosteric and pharmacolog-ical spectrum of NMDARs and provide a new structural basis for the development of next-generation GluN2B antagonists that have therapeutic potential in brain diseases. Small molecule therapeutic inhibitors targeting NMDA have recently been developed to target CNS disorders such as Alzheimer\u2019s disease. In the current study, a cheminformatics method was used to discover potential antagonists and to identify the structural requirements for Gly\/NMDA antagonism. In this case we have created a useful pharmacophore model with solid statistical values. Through pharmacophore mapping, the verified model was used to filter out virtual matches from the ZINC database. Assessing receptor-ligand binding mechanisms and affinities used molecular docking. To find the best hits, the GlideScore and the interaction of molecules with important amino acids were considered essential features. We found some molecular inhibitors, namely, ZINC13729211, ZINC07430424, ZINC08614951, ZINC60927204, ZINC12447511, and ZINC18889258 with high binding affinity using computational methods. The molecules in our studies showed characteristics such as good stability, hydrogen bonding and higher binding affinities in the solvation-based assessment method than ifenprodil with acceptable ADMET profile. Moreover, these six leads have been proposed as potential new perspectives for exploring potent Gly\/NMDA receptor antagonists. In addition, it can be tested in the laboratory for potential therapeutic strategies for both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> research.<\/jats:p>","DOI":"10.3389\/fphar.2023.1208968","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T07:02:32Z","timestamp":1687330952000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Targeting NMDA receptor in Alzheimer\u2019s disease: identifying novel inhibitors using computational approaches"],"prefix":"10.3389","volume":"14","author":[{"given":"Arif Jamal","family":"Siddiqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riadh","family":"Badraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadaf","family":"Jahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Merae","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maqsood Ahmed","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andleeb","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/ph6040480","article-title":"NMDA receptor antagonists for treatment of depression","volume":"6","author":"Ates-Alagoz","year":"2013","journal-title":"Pharm. (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11064-018-2491-1","article-title":"AMPA-type glutamate receptor conductance changes and plasticity: Still a lot of noise","volume":"44","author":"Benke","year":"2019","journal-title":"Neurochem. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/pro.3331","article-title":"RCSB Protein Data Bank: Sustaining a living digital data resource that enables breakthroughs in scientific research and biomedical education","volume":"27","author":"Burley","year":"2018","journal-title":"Protein Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"104864","DOI":"10.1016\/j.isci.2022.104864","article-title":"NMDA receptor-targeted enrichment of CaMKII\u03b1 improves fear memory","volume":"25","author":"Chifor","year":"2022","journal-title":"iScience"},{"key":"B5","doi-asserted-by":"publisher","first-page":"11677","DOI":"10.3390\/ijms222111677","article-title":"Glutamate and GABA in microglia-neuron cross-talk in Alzheimer\u2019s disease","volume":"22","author":"Czapski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/00008877-199508000-00007","article-title":"Modulation of learning processes by ionotropic glutamate receptor ligands","volume":"6","author":"Danysz","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/bs.apha.2020.04.004","article-title":"Clinical overview of NMDA-R antagonists and clinical practice","volume":"89","author":"Davoudian","year":"2020","journal-title":"Adv. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1146\/annurev.ne.16.030193.001231","article-title":"The role of NMDA receptors in information processing","volume":"16","author":"Daw","year":"1993","journal-title":"Annu. Rev. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuroscience.2005.08.040","article-title":"Post-training N-methyl-D-aspartate receptor blockade offers protection from retrograde interference but does not affect consolidation of weak or strong memory traces in the water maze","volume":"137","author":"Day","year":"2006","journal-title":"Neuroscience"},{"key":"B10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","article-title":"Phase: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results","volume":"20","author":"Dixon","year":"2006","journal-title":"J. computer-aided Mol. Des."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neuron.2011.07.008","article-title":"How glutamate receptor subunits mix and match: Details uncovered","volume":"71","author":"Hansen","year":"2011","journal-title":"Neuron"},{"key":"B13","doi-asserted-by":"publisher","first-page":"100105","DOI":"10.1074\/jbc.REV120.008207","article-title":"The essential elements of Alzheimer's disease","volume":"296","author":"Lei","year":"2021","journal-title":"J. Biol. Chem."},{"key":"B14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJM199403033300907","article-title":"Excitatory amino acids as a final common pathway for neurologic disorders","volume":"330","author":"Lipton","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1152\/jn.00602.2003","article-title":"Presynaptic activity and Ca2+ entry are required for the maintenance of NMDA receptor-independent LTP at visual cortical excitatory synapses","volume":"92","author":"Liu","year":"2004","journal-title":"J. Neurophysiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-12-804766-8.00009-1","article-title":"Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer's disease and other dementias","volume":"167","author":"Lopez","year":"2019","journal-title":"Handb. Clin. neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1523\/JNEUROSCI.5252-10.2011","article-title":"Calcium microdomains near R-type calcium channels control the induction of presynaptic long-term potentiation at parallel fiber to purkinje cell synapses","volume":"31","author":"Myoga","year":"2011","journal-title":"J. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","article-title":"Directory of useful decoys, enhanced (DUD-E): Better ligands and decoys for better benchmarking","volume":"55","author":"Mysinger","year":"2012","journal-title":"J. Med. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"134110","DOI":"10.1063\/5.0018516","article-title":"Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS","volume":"153","author":"P\u00e1ll","year":"2020","journal-title":"J. Chem. Phys."},{"key":"B20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/msj.20157","article-title":"Neuropathology of Alzheimer's disease","volume":"77","author":"Perl","year":"2010","journal-title":"Mt. Sinai J. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/ana.410190202","article-title":"Glutamate and the pathophysiology of hypoxic--ischemic brain damage","volume":"19","author":"Rothman","year":"1986","journal-title":"Ann. Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2000211","DOI":"10.1002\/minf.202000211","article-title":"Targeting Mycobacterium tuberculosis enoyl-acyl carrier protein reductase using computational tools for identification of potential inhibitor and their biological activity","volume":"40","author":"Sharma Kuldeep","year":"2021","journal-title":"Mol. Inf."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1016\/j.sjbs.2021.02.059","article-title":"Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19","volume":"28","author":"Sharma","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1900023","DOI":"10.1002\/minf.201900023","article-title":"Identification of potential inhibitors of cathepsin-B using shape & pharmacophore-based virtual screening, molecular docking and explicit water thermodynamics","volume":"39","author":"Sharma","year":"2020","journal-title":"Mol. Inf."},{"key":"B26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijbiomac.2022.09.151","article-title":"Combining structure-based pharmacophore modeling and machine learning for the identification of novel BTK inhibitors","volume":"222","author":"Sharma","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1080\/07391102.2018.1454851","article-title":"In silico identification and design of potent peptide inhibitors against PDZ-3 domain of Postsynaptic Density Protein (PSD-95)","volume":"37","author":"Sharma","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2023.2181646","article-title":"Identifying novel and potent inhibitors of EGFR protein for the drug development against the breast cancer","author":"Siddiqui","year":"","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3390\/math11061464","article-title":"Targeting monoamine oxidase B for the treatment of Alzheimer\u2019s and Parkinson\u2019s diseases using novel inhibitors identified using an integrated approach of machine learning and computer-aided drug design","volume":"11","author":"Siddiqui","year":"","journal-title":"Mathematics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3390\/medicina57101058","article-title":"Molecular docking and dynamics simulation revealed ivermectin as potential drug against schistosoma-associated bladder cancer targeting protein signaling: Computational drug repositioning approach","volume":"57","author":"Siddiqui","year":"2021","journal-title":"Medicina"},{"key":"B31","doi-asserted-by":"publisher","first-page":"106786","DOI":"10.1016\/j.compbiomed.2023.106786","article-title":"Computational insight into structural basis of human ELOVL1 inhibition","volume":"157","author":"Siddiqui","year":"","journal-title":"Comput. Biol. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1124\/mol.115.103036","article-title":"A novel binding mode reveals two distinct classes of NMDA receptor GluN2B-selective antagonists","volume":"89","author":"Stroebel","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1021\/acschemneuro.7b00329","article-title":"A novel negative allosteric modulator selective for GluN2C\/2D-containing NMDA receptors inhibits synaptic transmission in hippocampal interneurons","volume":"9","author":"Swanger","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.tins.2018.06.001","article-title":"Synaptic receptor diversity revealed across space and time","volume":"41","author":"Swanger","year":"2018","journal-title":"Trends Neurosci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.neuron.2022.01.026","article-title":"Rebuilding essential active zone functions within a synapse","volume":"110","author":"Tan","year":"2022","journal-title":"Neuron"},{"key":"B36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-014-1375-y","article-title":"Neuropathology and biochemistry of A\u03b2 and its aggregates in Alzheimer's disease","volume":"129","author":"Thal","year":"2015","journal-title":"Acta Neuropathol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1021\/acs.jcim.2c01253","article-title":"ZINC-22\u2500A free multi-billion-scale database of tangible compounds for ligand discovery","volume":"63","author":"Tingle","year":"2023","journal-title":"Database Tangible Compd. Ligand Discov."},{"key":"B38","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. theory Comput."},{"key":"B39","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.bbagen.2014.08.004","article-title":"CHARMM additive and polarizable force fields for biophysics and computer-aided drug design","volume":"1850","author":"Vanommeslaeghe","year":"2015","journal-title":"Biochimica Biophysica Acta (BBA)-General Subj."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer's disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","article-title":"ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties","volume":"49","author":"Xiong","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.str.2018.05.004","article-title":"Glutamate and glycine binding to the NMDA receptor","volume":"26","author":"Yu","year":"2018","journal-title":"Structure"},{"key":"B43","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2016.03.028","article-title":"Mechanism of NMDA receptor inhibition and activation","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: A fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1208968\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T07:02:35Z","timestamp":1687330955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1208968\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":44,"alternative-id":["10.3389\/fphar.2023.1208968"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1208968","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]},"article-number":"1208968"}}